NDC 42291-033 – Dabigatran
Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Oral
Product NDC42291-033
Product details
- Brand name
- Dabigatran
- Generic name
- Dabigatran Etexilate
- Labeler
- AvKARE
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213879
- Marketed since
- November 27, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Direct Thrombin Inhibitor
Active ingredients
- Dabigatran Etexilate Mesylate 75 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-033-60 | 60 CAPSULE in 1 BOTTLE (42291-033-60) | Nov 27, 2024 |
Other Dabigatran products
- 50090-7530 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · A-S Medication Solutions
- 50090-7531 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · A-S Medication Solutions
- 60687-963 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · American Health Packaging
- 60687-974 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · American Health Packaging
- 42291-034 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · AvKARE
- 50268-200 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · AvPAK
- 72205-202 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Novadoz Pharmaceuticals LLC
- 72205-203 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Novadoz Pharmaceuticals LLC
- 72205-204 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Novadoz Pharmaceuticals LLC